Hippocampal sclerosis dementia differs from hippocampal sclerosis in frontal lobe degeneration

Catalina Amador-Ortiz1, Zeshan Ahmed, Cynthia Zehr

  • 1Department of Pathology (Neuropathology) and Neuroscience, Mayo Clinic College of Medicine, Jacksonville, FL, USA.

Acta Neuropathologica
|January 2, 2007
PubMed

Insights

Hippocampal sclerosis dementia (HSD) differs from hippocampal sclerosis (HS) in frontotemporal lobar degeneration. HSD shows greater neuronal loss, synaptic loss, and gliosis, particularly in older individuals.

Area of Science:

  • Neuropathology
  • Neurodegenerative Diseases

Background:

  • Hippocampal sclerosis (HS) involves neuronal loss and gliosis in the hippocampus, linked to various neurodegenerative disorders.
  • Hippocampal sclerosis dementia (HSD) presents without other associated pathologies.
  • Systematic comparison of HSD and HS within frontotemporal lobar degeneration with ubiquitin immunoreactive inclusions (FTLD-U) is lacking.

Purpose of the Study:

  • To investigate the distinct neuropathological features of HSD compared to HS associated with FTLD-U.

Main Methods:

  • Studied eight HSD cases and ten HS with FTLD-U cases using Nissl and PAS stains.
  • Immunohistochemistry for glial fibrillary acidic protein, HLA-DR, synaptophysin, and 4-R tau.
  • Image analysis quantified immunoreactivity in hippocampal CA1 and subiculum.

Main Results:

  • HSD cases were more frequent in the elderly.
  • HSD exhibited more significant neuronal and synaptic loss compared to HS with FTLD-U.
  • Greater reactive gliosis was observed in HSD.
  • Corpora amylacea were more frequent in HSD, while argyrophilic grains showed no difference.

Conclusions:

  • Hippocampal sclerosis dementia (HSD) is neuropathologically distinct from HS associated with FTLD-U.
  • HSD is characterized by more severe neuronal and synaptic degeneration and gliosis.
  • These findings highlight key differences in the pathological profiles of these conditions.

Related Concept Videos

Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Role of Hippocampus in Memory01:19

Role of Hippocampus in Memory

The hippocampus, a critical brain structure, plays an essential role in memory processing, particularly in the formation and retrieval of memory. This small, seahorse-shaped region is located within the medial temporal lobe, with one hippocampus in each brain hemisphere. Experimental studies involving lesions in the hippocampi of rats have demonstrated significant impairments in tasks such as object recognition and maze navigation, indicating the hippocampus involvement in both recognition and...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.